Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis

Pancreatology

Volumn 7, Issue 5-6, 2007, Pages 479-490

  Singh, L ^a   Bakshi, D K ^a   Majumdar, S ^a   Vasishta, R K ^a   Arora, S K ^a   Wig, J D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chemokine receptors; Chemokines; Chronic pancreatitis; CXCL10; CXCR3

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; RANTES;

ACINAR CELL; ADULT; ARTICLE; CELL MEMBRANE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 35348851468     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000108965     Document Type: Article

References (42)

1. Owyang C, Levitt M: Chronic pancreatitis; in Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE (eds): Textbook of Gastroenterology. New York, Lippincott, 1991, vol 2, pp 1874-1893.
2. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen R, Dimagno EP, Andren-Sandberg A, Domellof L: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-1437.
3. Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W: Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148-155.
4. Lang C, Gyr K, Stalder GA, Gillessen D: Assessments of exocrine pancreatic function by oral administration of N-benzoyl- L -tyrosyl- p-aminobenzoic acid. Br J Surg 1981;68:771-775.
5. Mori M, Hariharan M, Anandakumar M, Tsutsumi M, Ishikawa O, Konishi Y, Chellam VG, John M, Praseeda I, Priya R, Narendranathan M: A case-control study on risk factors for pancreatic diseases in Kerala, India. Hepatogastroenterology 1999;46:25-30.
6. Chari ST, Mohan V, Jayanthi V, Snehalatha C, Malathi S, Viswanathan M, Madanagopalan N: Comparative study of the clinical profiles of alcoholic chronic pancreatitis and tropical chronic pancreatitis in Tamilnadu, South India. Pancreas 1992;7:52-58.
7. Goecke H, Forssmann U, Uguccioni M, Friess H, Conejo-Garcia JR, Zimmermann A, Baggiolini M, Buchler MW: Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5. Surgery 2000;128:806-814.
8. Saurer L, Reber P, Schaffner T, Buchler MW, Buri C, Kappeler A, Walz A, Friess H, Mueller C: Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-367.
9. Han B, Longsdon CD: Cholecystokinin induction of mob-1 chemokine expression in pancreatitis acinar cells requires NF-B activation. Am J Physiol 1999;277:C74-C82.
10. Soejima K, Rollins BJ: A functional IFN-γ-inducible protein-10/CXCL 10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol 2001;167:6576-6582.
11. Bhatnagar A, Wig JD, Majumdar S: Expression of activation, adhesion molecules and intracellular cytokines in acute pancreatitis. Immunol lett 2001;77:133-141.
12. Favoloro J, Treisman R, Karmen R: Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol 1980;65:718-749.
13. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M: Expression of IP-10/CXCL10/CXCL10 and MIG/CXCL9/CXCL9 in the thyroid and increased level of IP-10/CXCL10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 2002;161:195-206.
14. Pechkovsky DV, Goldmann T, Ludwig C, Prasse A, Vollmer E, Muller-Quernheim J, Zissel G: CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. Resp Res 2005;6:75-86.
15. Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, Brack-Werner R, Poli G: Upregulated expression of interleukin-8, RANTES/CCL5 and chemokine receptors in human astrocytic cells infected with HIV-1. J Neurol Virol 2000;6:75-83.
16. Nair MP, Chadha KC, Hewitt RG, Mahajan S, Sweet A, Schwartz SA: Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 2000;7:96-100.
17. Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, Roach AG, Westwick J, Williams RJ: Human vascular smooth muscle cells expressed receptors for CC chemokines. Arterioscler Thromb Vasc Biol 1998;18:397-403.
18. Martini G, Zulian F, Calabrese F, Bortoli M, Facco M, Cabrelle A, Valente M, Zacchello F, Agostini C: CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis. Arthritis Res Ther 2005;7:241-249.
19. Ou H, Shen YH, Utama B, Wang J, Wang X, Coselli J, Wang XL: Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler Thromb Vasc Biol 2005;25:2509-2514.
20. Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Doi R, Kato M, Shimada Y, Imamura M: Imunohistochemical analysis of Bcl-2, Bax, Bcl-X and Mcl-1 expression in pancreatic cancers. Oncology 1999;56:73-82.
21. Laemmli UK: Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
22. Towbin H, Staechelin T, Gordon J: Electrophoresis transfer of protein from polyacrylamide gels to nitrocellulose sheets procedure and same applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
23. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 1997;25:3389-3402.
24. Baggiolini M: Chemokines and leukocyte traffic. Nature 1997;392:565-928.
25. Singh UP, Singh S, Iqbal N, Weaver CT, McGhee JR, Lillard JW Jr: IFN-γ-inducible chemokines enhance adaptive immunity and colitis. J Inter Cyto Res 2003;23:591-600.
26. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Selle bjerg F, Strieter RM, Frederiksen JL, Ransohoff RM: Expression of specific chemokines and chemokine receptors in central nervous system of multiple sclerosis patients. J Clin Invest 1999;103:807-815.
27. Neville LF, Mathiak G, Bagasra O: The immunobiology of interferon-gamma inducible protein 10 kD (IP-10/CXCL10): a novel, pleiotropic member of the C-X-C chemokine super family. Cytokine Growth Factor Rev 1997;8:207-219.
28. Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D: Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol Cell Biol 2005;25:6247-6258.
29. Bateman AC, Turner SM, Thomas KS, McCrudden PR, Fine DR, Johnson PA, Johnson CD, Iredale JP: Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function. Gut 2002;50:542-548.
30. Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Cosmi L, Galli G, Salvadori M, Maggi E, Serio M: IP-10/CXCL10 and MIG/CXCL9 production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 2002;13:53-64.
31. Walz A, Schmutz P, Mueller C, Schnyder-Candrian S: Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukocyte Biol 1997;62:604-611.
32. Segerer S, Banas B, Wornle M, Schmid H, Cohen CD, Kretzler M, Mack M, Kiss E, Nelson PJ, Schlondorff D, Grone HJ: CXCR3 is involved in tubulointerstitial injury in human gloumerulonephritis . Am J Pathol 2004;164:635-649.
33. Teleshova N, Pashenkov M, Huang YM, Soderstrom M, Kivisakk P, Kostulas V, Haglund M, Link H: Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid. J Neurol 2002;249:723-729.
34. Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA: Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm Bowel Dis 2001;7:281-286.
35. Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001;194:398-405.
36. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR: The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746-754.
37. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001;276:2986-2991.
38. Rollins BJ: Chemokines. Blood 1997;90:909-928.
39. Rottmann JB, Ganley KP, Wallman K: Cellular localization of the chemokine receptor CCR5. Am J Pathol 1997;151:1341-1351.
40. Douglas MR, Morrison KE, Salmon M, Buckley CD: Why does inflammation persist: a dominant role for stromal microenvironment? Expert Rev Mol Med 2002;4:1-18.
41. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD: The T cell-specific CXC chemokines IP-10/CXCL10, MIG/CXCL9, and I-TAC/CXCL11 are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-3558.
42. Duque N, Gomez-Guerrero C, Egido J: Interaction of IgA with Fcγ receptors of human mesangial cells activates transcription factor nuclear factor-β and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-γ inducible protein 10. J Immunol 1997;159:3474-3482.